Intended use: For the quantitative determination of Antithrombin in human citrated plasma on the IL Coagulation systems.
Principle: Based on a synthetic chromogenic substrate and on FXa inactivation.
Measurement principle
AT + Heparin 
[AT • Heparin]
[AT • Heparin] + FXa (excess) [AT • Heparin • FXa] + FXa (residual)
S-2765 + FXa (residual) Peptide + pNA
Vials and volumes:
- 4 x 4 mL FXa Reagent (liq)
- 2 x 2 mL Chromogenic Substrate S-2765 (liq)
*ACL, ACL TOP, and HemosIL are trademarks of Instrumentation Laboratory.
Life Science Research
